A family of drug transporters: The multidrug resistance-associated proteins

Journal of the National Cancer Institute

Volumn 92, Issue 16, 2000, Pages 1295-1302

  Borst, Piet ^a   Evers, Raymond ^a   Kool, Marcel ^a   Wijnholds, Jan ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTHRACYCLINE; ANTIMONY; ANTIRETROVIRUS AGENT; ARSENIC TRIOXIDE; BISANTRENE; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IDARUBICIN; MELPHALAN; MEMBRANE PROTEIN; METHOTREXATE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; NUCLEOSIDE ANALOG; PACLITAXEL; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; ZIDOVUDINE;

CANCER CHEMOTHERAPY; DRUG TRANSPORT; DUBIN JOHNSON SYNDROME; ENZYME SPECIFICITY; HUMAN; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; REVIEW; SEQUENCE HOMOLOGY;

EID: 0034674901     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.16.1295     Document Type: Review

References (93)

1. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells
2. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cel mutants
3. P-glycoprotein-a mediator of multidrug resistance in tumour cells
4. Genetic dissection of the function of mammalian P-glycoproteins
5. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
6. Structure of the human MDR3 gene and physical mapping of the human MDR locus
7. The sister of P-glycoprotein represents the canalicular bite salt export pump of mammalian liver
8. Characterization of the human ABC superfamily: Isolation and mapping of 21 new genes using the expressed sequence tags database
9. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
10. Structural, mechanistic and clinical aspects of MRP1
11. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
12. The multidrug resistance protein family
13. Multidrug resistant proteins
14. Structure and function of ABC transporters
15. Functional multidrug resistance protein (MRP) lacking the N-terminal transmembrane domain
16. 4 transport by co-expression of both half-molecules of human multidrug resistance protein in insect cells
17. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein
18. 4 and structurally related conjugates
19. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
20. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump
21. The ATP-dependent glutathione S-conjugate export pump
22. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein
23. Hepatobiliary secretion of organic compounds; Molecular mechanisms of membrane transport
24. Regulation of organic anion transport in the liver
25. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
26. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
27. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
28. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
29. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
30. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAt (MRP2) cDNA
31. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
32. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
33. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light
34. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein
35. 4 and chemotherapeutic agents in membrane vesicles
36. Characterization of vincristine transport by the M(T) 190,000 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione
37. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1
38. Evidence that multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins
39. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells
40. Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues
41. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)
42. MRP3, an organic anion transporter able to transport anti-cancer drugs
43. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats
44. MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte
45. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
46. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
47. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs
48. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells
49. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells
50. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
51. The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line
52. Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines
53. ARA, a novel ABC transporter, is located at 16p 13.1, is deleted in inv(16) leukemias, and is shown to be expressed in primitive hematopoietic precursors
54. P-glycoprotein-mediated multidrug resistance: Experimental and clinical strategies for its reversal
55. Pharmacologic approaches to reversing multidrug resistance
56. Future perspectives for the development of P-glycoprotein modulators
57. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918
58. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2
59. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells
60. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
61. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
62. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
63. Reprod Toxicol
64. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells
65. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein
66. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione
67. Newe insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models
68. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage
69. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
70. Transepithelial transport of organic anions across the choroid plexus: Possible involvement of organic anion transporter and multidrug resistance-associated protein
71. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
72. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response
73. Functional implications from the effects of 1-chloro-2,4-dinitrobenzene and ethacrynic acid on efflux routes for methotrexate and cholate in L1210 cells
74. MOAT4, a novel multispecific organic-anion transporter for glucuronides and mercapturates in mouse L1210 cells and human erythrocytes
75. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats
76. GS-X pump is functionally overexpressed in cis-diamminedichlroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation
77. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
78. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system
79. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
80. Double knockout of the MRP gene leads to increased drug sensitivity in vivo
81. Flip-flop of doxorubicin across erythrocyte and lipid membranes
82. A multidrug resistance transporter from human MCF-7 breast cancer cells
83. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
84. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
85. The mouse Bcrp1/Mxr/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin
86. Re: Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins
87. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis
88. Structure of the multidrug resistance P-glycoprotein
89. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
90. MRP, mode of action and role in MDR
91. Mutations in ABCC6 cause pseudoxanthoma elasticum
92. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum
93. Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter